Nextrna Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Nextrna Therapeutics

Access the complete profile.

Nextrna Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	40 Guest St Boston, MA 02135

Note: Revenues for privately held companies are statistical evaluations.


Nextrna Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Nextrna Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Nextrna Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Nextrna Therapeutics Annual Revenue and Growth Rate

Nextrna Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Nextrna Therapeutics's revenues are gauged from an analysis of company filings.

Nextrna Therapeutics's Income Statement (based on Industry Averages)

Nextrna Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Nextrna Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 27, 2022	34	47%	$50 MM
Complete list of funding rounds and total amounts in the Company Report

Market Share of Nextrna Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nextrna Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Nextrna Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 40 Guest St, Boston MA

Company	Headquarters	Revenue ($ MM)
YUMANITY THERAPEUTICS	Boston, MA	100
SENSORIUM THERAPEUTICS	Boston, MA	40

Future Competition: Nextrna Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Nextrna Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)